Evaluation of the Clinical and Genetic association between Myotonic Dystrophy Type 1 and Fuchs Endothelial Corneal Dystrophy
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 14-007285
Sponsor Protocol Number: 14-007285
About this study
The purpose of this study is to test for a clinical and genetic association between Myotonic Dystrophy Type 1 (DM1) and Fuchs endothelial corneal dystrophy (FECD).
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Subjects with DM1 which is genetically proven or clinically diagnosedFamily members of subjects with DM1 who are affected or unaffected by the disease
- Ability to understand and willingness to sign the informed consent documents
- Age ≥18 yrs
Exclusion Criteria:
- Unable or unwilling to sign or understand the informed consent documents
- Unwilling to participate in the research
- Unwilling to allow genetic testing
- Unwilling to allow samples to be sent to other institutions for testing
- Not meeting the inclusion criteria
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Keith Baratz, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available